| 商品名称 | Altargo |
|---|---|
| 适用类别 | Human |
| 治疗领域 | Impetigo;Staphylococcal Skin Infections |
| 通用名/非专利名称 | retapamulin |
| 活性成分 | retapamulin |
| 产品号 | EMEA/H/C/000757 |
| 患者安全信息 | No |
| 许可状态 | Withdrawn |
| ATC编码 | D06AX13 |
| 是否额外监管 | No |
| 是否仿制药或hybrid药物 | No |
| 是否生物类似药 | No |
| 是否附条件批准 | No |
| 是否特殊情形 | No |
| 是否加速审评 | No |
| 是否罕用药 | No |
| 上市许可日期 | 2007/05/24 |
| 上市许可开发者/申请人/持有人 | Glaxo Group Ltd |
| 人用药物治疗学分组 | Antibiotics and chemotherapeutics for dermatological use |
| 兽用药物治疗学分组 | |
| 欧盟委员会决定日期 | 2015/11/09 |
| 修订号 | 15 |
| 治疗适应症 | Short term treatment of the following superficial skin infections: impetigo; infected small lacerations, abrasions or sutured wounds. See sections 4.4 and 5.1 for important information regarding the clinical activity of retapamulin against different types of Staphylococcus aureus. Consideration should be given to official guidance on the appropriate use of antibacterial agents. |
| 适用物种 | |
| 兽用药物ATC编码 | |
| 首次发布日期 | 2015/11/09 |
| 最后更新日期 | 2019/03/15 |
| 产品说明书 | https://www.ema.europa.eu/en/documents/product-information/altargo-epar-product-information_en.pdf |
| 公共评估报告 | https://www.ema.europa.eu/en/medicines/human/EPAR/altargo |